RNU6-1224P

Across TCGA pan-cancer cohorts, RNU6-1224P RNA is linked to patient survival in 12 of 34 cancer types, making it the most broadly survival-associated RNU6-1224P data layer.

The strongest signal is observed in mesothelioma (MESO), where higher RNU6-1224P RNA is associated with worse overall survival. In most high-consensus cancer types, elevated RNU6-1224P expression acts as an unfavorable survival marker.

MESO, LUAD, and KIRC are the cancer types where RNU6-1224P RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
MESO	OS	Tertile	IV	0.036	0.602	<.001	126	view →
LUAD	OS	Tertile	II,III,IV	0.107	0.712	<.001	117	view →
KIRC	DFS	Tertile	All	0.413	0.808	<.001	66	view →
THYM	DFS	Tertile	III,IV	0.208	0.816	.001	54	view →
READ	DFS	Tertile	III,IV	0.190	0.767	<.001	54	view →
ACC	DFS	Tertile	All	0.048	0.667	<.001	54	view →
BRCA	DFS	Tertile	IV	0.175	0.730	.005	36	view →
PAAD	OS	Tertile	II,III,IV	0.375	0.592	.024	36	view →
SARC	OS	Tertile	All	0.143	0.510	.001	33	view →
STAD	OS	Tertile	II,III,IV	0.281	0.726	<.001	27	view →
SKCM	OS	Tertile	All	0.164	0.785	<.001	18	view →
COAD	OS	Tertile	III,IV	0.239	0.791	.014	9	view →

Pink = unfavorable, green = favorable. Showing the 12 strongest of 12 lineages.

RNU6-1224P–MESO (OS)

Open the MESO breakdown →